JPS4633956Y1
(pt)
|
1967-06-09 |
1971-11-24 |
|
|
JPS5959330U
(ja)
|
1982-10-13 |
1984-04-18 |
斉藤 晃正 |
通気性防水部材
|
JPS614960A
(ja)
|
1984-06-19 |
1986-01-10 |
Fuji Photo Film Co Ltd |
分析試薬および多層化学分析要素
|
CA2061159A1
(en)
|
1991-02-26 |
1992-08-27 |
Michael A. Poss |
Imidazole and benzimidazole derivatives
|
JPH04346987A
(ja)
|
1991-05-23 |
1992-12-02 |
Nippon Soda Co Ltd |
イミダゾピラジン誘導体及びその電子写真感光体としての利用
|
DE4129603A1
(de)
|
1991-09-06 |
1993-03-11 |
Thomae Gmbh Dr K |
Kondensierte 5-gliedrige heterocyclen, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
|
US5234923A
(en)
|
1991-12-16 |
1993-08-10 |
E. R. Squibb & Sons, Inc. |
Substitute indole and benzimidazole derivatives
|
AU3761393A
(en)
|
1992-03-20 |
1993-10-21 |
Wellcome Foundation Limited, The |
Indole derivatives with antiviral activity
|
JP3383820B2
(ja)
|
1993-06-02 |
2003-03-10 |
独立行政法人産業技術総合研究所 |
有機非線形光学材料
|
DE4330959A1
(de)
|
1993-09-09 |
1995-03-16 |
Schering Ag |
Neue Benzimidazolderivate, Verfahren zu ihrer Herstellung und ihre pharmazeutische Verwendung
|
DE4338770A1
(de)
|
1993-11-12 |
1995-05-18 |
Matthias Dr Lehr |
Indol-2-alkansäuren und ihre Derivate als Hemmstoffe der Phospholipase A¶2¶
|
US5482960A
(en)
|
1994-11-14 |
1996-01-09 |
Warner-Lambert Company |
Nonpeptide endothelin antagonists
|
JPH08157461A
(ja)
|
1994-12-07 |
1996-06-18 |
Sankyo Co Ltd |
スルホン誘導体
|
IL122427A0
(en)
|
1995-06-07 |
1998-06-15 |
Sugen Inc |
Pharmaceutical compositions and methods for inhibition of adaptor protein/tyrosine kinase interactions
|
US6630496B1
(en)
|
1996-08-26 |
2003-10-07 |
Genetics Institute Llc |
Inhibitors of phospholipase enzymes
|
US5751787A
(en)
|
1996-09-05 |
1998-05-12 |
Nanoptics, Inc. |
Materials and methods for improved radiography
|
ES2215242T3
(es)
|
1996-11-19 |
2004-10-01 |
Amgen Inc. |
Agentes antiinflamatorios de pirrol condensado sustituido con arilo y heteroarilo.
|
AU6691798A
(en)
|
1997-03-07 |
1998-09-22 |
Metabasis Therapeutics, Inc. |
Novel indole and azaindole inhibitors of fructose-1,6-bisphosphatase
|
CA2291647A1
(en)
|
1997-06-05 |
1998-12-10 |
Merck & Co., Inc. |
Antagonists of gonadotropin releasing hormone
|
AU1124399A
(en)
|
1997-10-28 |
1999-05-17 |
Merck & Co., Inc. |
Antagonists of gonadotropin releasing hormone
|
CN1310706A
(zh)
|
1998-02-25 |
2001-08-29 |
遗传研究所有限公司 |
磷脂酶抑制剂
|
ID26123A
(id)
|
1998-02-25 |
2000-11-23 |
Genetics Inst |
Penghambat-penghambat phospholipase a2
|
JP2002504539A
(ja)
|
1998-02-25 |
2002-02-12 |
ジェネティックス・インスチチュート・インコーポレーテッド |
ホスホリパーゼ酵素の阻害剤
|
JP2002510623A
(ja)
|
1998-04-02 |
2002-04-09 |
メルク エンド カムパニー インコーポレーテッド |
抗糖尿病薬
|
US6534503B1
(en)
|
1998-04-28 |
2003-03-18 |
Lion Bioscience Ag |
Melanocortin receptor-3 ligands to treat sexual dysfunction
|
AU4981199A
(en)
|
1998-07-08 |
2000-02-01 |
Gregory N. Beatch |
Compositions and methods for modulating sexual activity
|
AU1738900A
(en)
|
1998-11-19 |
2000-06-05 |
Nortran Pharmaceuticals Inc. |
Serotonin ligands as pro-erectile compounds
|
JP4221129B2
(ja)
|
1999-02-15 |
2009-02-12 |
富士フイルム株式会社 |
含窒素ヘテロ環化合物、有機発光素子材料、有機発光素子
|
WO2001021634A1
(en)
|
1999-09-21 |
2001-03-29 |
Lion Bioscience Ag |
Benzimidazole derivatives and combinatorial libraries thereof
|
EP1226136B1
(en)
|
1999-10-19 |
2004-12-29 |
Merck & Co., Inc. |
Tyrosine kinase inhibitors
|
JP2003512353A
(ja)
|
1999-10-19 |
2003-04-02 |
メルク エンド カムパニー インコーポレーテッド |
チロシンキナーゼ阻害剤
|
ATE311385T1
(de)
|
1999-10-27 |
2005-12-15 |
Novartis Pharma Gmbh |
Thiazol und imidazo(4,5-b)pyridin verbindungen und ihre verwendung als pharmazeutika
|
RU2273642C2
(ru)
|
1999-12-22 |
2006-04-10 |
Метабэйсис Терапьютикс, Инк. |
Бисамидатные фосфонатные соединения, являющиеся ингибиторами фруктозо-1,6-бисфосфатазы
|
CZ20022353A3
(cs)
|
2000-01-07 |
2003-02-12 |
Universitaire Instelling Antwerpen |
Deriváty purinu, způsob jejich přípravy a jejich použití
|
PT1246808E
(pt)
|
2000-01-14 |
2011-11-30 |
Bayer Schering Pharma Ag |
1,2¿diarilbenzimidazol para o tratamento de doenças associadas a uma activação das micróglias
|
CA2402516A1
(en)
|
2000-03-20 |
2001-09-27 |
Roopa Rai |
Non-amidine containing protease inhibitors
|
WO2002009702A2
(en)
|
2000-07-28 |
2002-02-07 |
Inspire Pharmaceuticals, Inc. |
Use of indole derivatives for the manufacture of a medicament for reducing intracular pressure
|
EP1311502A1
(en)
|
2000-08-17 |
2003-05-21 |
Celltech R&D Limited |
Bicyclic heteroaromatic derivatives for the treatment of immune and inflammatory disorders
|
DK1315492T3
(da)
|
2000-09-06 |
2008-10-13 |
Ortho Mcneil Pharm Inc |
Anvendelse af substituerede pyrazoler til behandling af allergier
|
HN2001000224A
(es)
|
2000-10-19 |
2002-06-13 |
Pfizer |
Compuestos de imidazol condensado con arilo o heteroarilo como agentes anti - inflamatorios y analgesicos.
|
WO2002046168A1
(en)
|
2000-12-07 |
2002-06-13 |
Astrazeneca Ab |
Therapeutic benzimidazole compounds
|
MXPA03005140A
(es)
|
2000-12-08 |
2004-10-15 |
Johnson & Johnson |
Compuestos de pirrolina sustituidos con indazolilo como inhibidores de cinasa.
|
US20030109714A1
(en)
|
2001-03-22 |
2003-06-12 |
Neil Wishart |
Transition metal mediated process
|
US20030009034A1
(en)
|
2001-03-22 |
2003-01-09 |
Neil Wishart |
Transition metal mediated process
|
GB0115393D0
(en)
|
2001-06-23 |
2001-08-15 |
Aventis Pharma Ltd |
Chemical compounds
|
DE10135050A1
(de)
|
2001-07-09 |
2003-02-06 |
Schering Ag |
1-Ary1-2-N-, S- oder O-substituierte Benzimidazolderivate, deren Verwendung zur Herstellung von Arzneimitteln sowie diese Derivate enthaltende pharmazeutische Präparate
|
US6927293B2
(en)
|
2001-08-30 |
2005-08-09 |
Merck & Co., Inc. |
Tyrosine kinase inhibitors
|
EP1427408A4
(en)
|
2001-09-17 |
2005-10-26 |
Bristol Myers Squibb Co |
CYCLIC HYDROXAMINE ACIDS AS INHIBITORS OF MATRIX METALLOPROTEINASES AND / OR TNF-a-CONVERTASE (TACE TNF-a-CONVERTING ENZYM)
|
EP1442028A4
(en)
|
2001-11-06 |
2009-11-04 |
Bristol Myers Squibb Co |
SUBSTITUTED ACID DERIVATIVES, WHICH APPRECIATE AS ANTIDIBILICS AND AGENTS AGAINST OBESITAS, AND METHODS
|
US7528165B2
(en)
|
2001-12-13 |
2009-05-05 |
National Health Research Institutes |
Indole compounds
|
US7632955B2
(en)
|
2001-12-13 |
2009-12-15 |
National Health Research Institutes |
Indole compounds
|
US7244847B2
(en)
|
2002-02-06 |
2007-07-17 |
Isis Pharmaceuticals, Inc. |
Benzimidazole compounds
|
DE10207843A1
(de)
|
2002-02-15 |
2003-09-04 |
Schering Ag |
Mikrolia-Inhibitoren zur Unterbrechung von Interleukin 12 und IFN-gamma vermittelten Immunreaktionen
|
GB0206860D0
(en)
|
2002-03-22 |
2002-05-01 |
Glaxo Group Ltd |
Compounds
|
NZ535748A
(en)
|
2002-04-12 |
2007-06-29 |
Pfizer |
Use of EP4 receptor ligands in the treatment of IL-6 involved diseases
|
AU2003225295A1
(en)
|
2002-05-08 |
2003-11-11 |
Janssen Pharmaceutica N.V. |
Substituted pyrroline kinase inhibitors
|
US6951881B2
(en)
|
2002-05-10 |
2005-10-04 |
Wyeth |
(1-substituted-indol-3-yl) alkylidenehydrazinecarboximidamide derivatives as 5-hydroxytryptamine-6 ligands
|
DE60323749D1
(de)
|
2002-06-05 |
2008-11-06 |
Janssen Pharmaceutica Nv |
Substituierte pyrroline als kinase inhibitoren
|
US20050282733A1
(en)
|
2002-06-27 |
2005-12-22 |
Prins Johannes B |
Differentiation modulating agents and uses therefor
|
EP1388541A1
(en)
*
|
2002-08-09 |
2004-02-11 |
Centre National De La Recherche Scientifique (Cnrs) |
Pyrrolopyrazines as kinase inhibitors
|
US20040142958A1
(en)
|
2002-12-13 |
2004-07-22 |
Neurogen Corporation |
Combination therapy for the treatment of pain
|
WO2004063151A2
(en)
|
2003-01-03 |
2004-07-29 |
Bristol-Myers Squibb Company |
Novel tyrosine kinase inhibitors
|
EP1606266A4
(en)
|
2003-03-21 |
2008-06-25 |
Smithkline Beecham Corp |
CHEMICAL COMPOUNDS
|
US20060035945A1
(en)
|
2003-05-30 |
2006-02-16 |
Giorgio Attardo |
Triheterocyclic compounds, compositions, and methods for treating cancer or viral diseases
|
US7312215B2
(en)
|
2003-07-29 |
2007-12-25 |
Bristol-Myers Squibb Company |
Benzimidazole C-2 heterocycles as kinase inhibitors
|
ES2222832B1
(es)
|
2003-07-30 |
2006-02-16 |
Laboratorios Del Dr. Esteve, S.A. |
Derivados de 6-indolilsulfonamidas, su preparacion y su aplicacion como medicamentos.
|
ES2228267B1
(es)
|
2003-07-30 |
2006-07-01 |
Laboratorios Del Dr. Esteve, S.A. |
Combinacion de sustancias activas conteniendo al menos un compuesto con afinidad por el receptor del neuropeptido y (npy) y al menos un compuesto con afinidad por el receptor 5-ht6.
|
ES2228268B1
(es)
|
2003-07-30 |
2006-07-01 |
Laboratorios Del Dr. Esteve, S.A. |
Combinacion de sustancias activas conteniendo al menos un compuesto con afinidad por el receptor del neuropeptido y (npy) y al menos un compuesto con afinidad por el receptor 5-ht6.
|
WO2005025579A1
(en)
|
2003-09-10 |
2005-03-24 |
Merck & Co., Inc. |
17-heterocyclic-4-azasteroid derivatives as androgen receptor modulators
|
AU2004270733B2
(en)
|
2003-09-11 |
2011-05-19 |
Itherx Pharma, Inc. |
Cytokine inhibitors
|
US20050164300A1
(en)
|
2003-09-15 |
2005-07-28 |
Plexxikon, Inc. |
Molecular scaffolds for kinase ligand development
|
WO2005041951A2
(en)
|
2003-10-28 |
2005-05-12 |
Rigel Pharmaceuticals, Inc. |
Rhodanine derivatives for use as antiviral agents
|
EP1532980A1
(en)
|
2003-11-24 |
2005-05-25 |
Novo Nordisk A/S |
N-heteroaryl indole carboxamides and analogues thereof, for use as glucokinase activators in the treatment of diabetes
|
US20070054902A1
(en)
|
2003-12-02 |
2007-03-08 |
Shionogi & Co., Ltd. |
Isoxazole derivatives as peroxisome proliferator-activated receptors agonists
|
US7791047B2
(en)
|
2003-12-12 |
2010-09-07 |
Semequip, Inc. |
Method and apparatus for extracting ions from an ion source for use in ion implantation
|
WO2005065686A1
(en)
|
2004-01-07 |
2005-07-21 |
Adipogen Pharmaceuticals Pty Limited |
Differentiation modulating agents and uses therefor
|
JPWO2005108370A1
(ja)
|
2004-04-16 |
2008-03-21 |
味の素株式会社 |
ベンゼン化合物
|
JP2007533753A
(ja)
|
2004-04-23 |
2007-11-22 |
タケダ サン ディエゴ インコーポレイテッド |
インドール誘導体及びキナーゼ阻害剤としてのその使用
|
CA2565200C
(en)
|
2004-05-07 |
2013-12-24 |
Exelixis, Inc. |
Raf modulators and methods of use
|
WO2005118580A2
(en)
|
2004-05-12 |
2005-12-15 |
The Government Of The United States Of America As Represented By The Secretary, Department Of Health |
Tricyclic compounds as inhibitors of the hypoxic signaling pathway
|
US7569604B2
(en)
|
2004-06-22 |
2009-08-04 |
Vertex Pharmaceuticals Incorporated |
Heterocyclic derivatives for modulation of calcium channels
|
US7868037B2
(en)
|
2004-07-14 |
2011-01-11 |
Ptc Therapeutics, Inc. |
Methods for treating hepatitis C
|
US7781478B2
(en)
|
2004-07-14 |
2010-08-24 |
Ptc Therapeutics, Inc. |
Methods for treating hepatitis C
|
JP2008506702A
(ja)
|
2004-07-14 |
2008-03-06 |
ピーティーシー セラピューティクス,インコーポレーテッド |
C型肝炎を治療するための方法
|
ES2246721B1
(es)
|
2004-08-10 |
2007-03-16 |
Laboratorios Del Dr. Esteve, S.A. |
Compuestos indolicos sustituidos, su preparacion y su uso como medicamentos.
|
EP1632491A1
(en)
|
2004-08-30 |
2006-03-08 |
Laboratorios Del Dr. Esteve, S.A. |
Substituted indole compounds and their use as 5-HT6 receptor modulators
|
GB0420719D0
(en)
|
2004-09-17 |
2004-10-20 |
Addex Pharmaceuticals Sa |
Novel allosteric modulators
|
MX2007004783A
(es)
|
2004-10-21 |
2007-05-11 |
Pfizer |
Inhibidores de la proteasa del virus de la hepatitis c, y composiciones y tratamientos que los usan.
|
MX2007005159A
(es)
|
2004-10-29 |
2007-06-26 |
Tibotec Pharm Ltd |
Derivados de pirimidina biciclicos inhibidores del vih.
|
US20100093767A1
(en)
|
2004-12-03 |
2010-04-15 |
Takeda San Diego, Inc. |
Mitotic Kinase Inhibitors
|
US7576222B2
(en)
|
2004-12-28 |
2009-08-18 |
Wyeth |
Alkynyl-containing tryptophan derivative inhibitors of TACE/matrix metalloproteinase
|
US20060156486A1
(en)
|
2005-01-14 |
2006-07-20 |
The Procter & Gamble Company |
Keratin dyeing compounds, keratin dyeing compositions containing them, and use thereof
|
GB0501999D0
(en)
|
2005-02-01 |
2005-03-09 |
Sentinel Oncology Ltd |
Pharmaceutical compounds
|
EP1853255A4
(en)
|
2005-02-22 |
2009-07-08 |
Gemin X Pharmaceuticals Canada |
METHODS FOR TREATING ARTHRITIS USING TRIHETEROCYCLIC COMPOUNDS
|
EP1702915A1
(en)
|
2005-03-14 |
2006-09-20 |
Cephalon France |
Process for enantioselective synthesis of single enantiomers of thio-substituted arylmethanesulfinyl derivatives by asymmetric oxidation
|
DE102005012875B4
(de)
|
2005-03-19 |
2006-11-16 |
Sanofi-Aventis Deutschland Gmbh |
Verwendung von Amino substituierten 8-N-Benzimidazolen
|
DE102005012872A1
(de)
|
2005-03-19 |
2006-09-28 |
Sanofi-Aventis Deutschland Gmbh |
Substituierte, bizyklische 8-Pyrrolidino-benzimidazole, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
DE102005012873B4
(de)
|
2005-03-19 |
2007-05-03 |
Sanofi-Aventis Deutschland Gmbh |
Aminocarbonyl substituierte 8-N-Benzimidazole, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
US20060229355A1
(en)
|
2005-04-08 |
2006-10-12 |
The Regents Of The University Of California |
3.3'-Diindolylmethane compositions inhibit angiogenesis
|
JP5080450B2
(ja)
|
2005-04-30 |
2012-11-21 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
新規なピペリジン置換インドール
|
JP2007056213A
(ja)
|
2005-08-26 |
2007-03-08 |
Fujifilm Corp |
焼結含油軸受油用組成物、並びにそれを用いた軸受け装置及び摺動部材
|
AU2006298164A1
(en)
|
2005-09-30 |
2007-04-12 |
Dainippon Sumitomo Pharma Co., Ltd. |
Novel fused pyrrole derivative
|
CN101287707A
(zh)
|
2005-10-13 |
2008-10-15 |
德福根有限公司 |
激酶抑制剂
|
EP1951315A2
(en)
|
2005-11-03 |
2008-08-06 |
Ilypsa, Inc. |
Phospholipase inhibitors, including multi-valent phospholipase inhibitors, and use thereof, including as lumen-localized phospholipase inhibitors
|
MX2008005666A
(es)
|
2005-11-03 |
2009-03-02 |
Ilypsa Inc |
Compuestos multivalentes de indol y uso de los mismos como inhibidores de fosfolipasa-a2.
|
CA2634250A1
(en)
|
2005-12-21 |
2007-07-05 |
Schering Corporation |
Phenoxypiperidines and analogs thereof useful as histamine h3 antagonists
|
CN101370775A
(zh)
|
2006-01-13 |
2009-02-18 |
惠氏公司 |
作为5-羟基色胺受体配体的经磺酰基取代1h-吲哚
|
JP2009523732A
(ja)
|
2006-01-13 |
2009-06-25 |
ピーティーシー セラピューティクス,インコーポレーテッド |
C型肝炎の治療方法
|
JP5376956B2
(ja)
|
2006-02-10 |
2013-12-25 |
スムミト コーポレーション ピーエルシー |
デュシェンヌ型筋ジストロフィーの治療
|
AU2007224367A1
(en)
|
2006-03-07 |
2007-09-13 |
The Procter & Gamble Company |
Compositions for oxidatively dyeing keratin fibers and methods for using such compositions
|
CN101400658A
(zh)
|
2006-03-10 |
2009-04-01 |
马林克罗特公司 |
光活性化合物和组合物及其用途
|
CN101443001B
(zh)
|
2006-03-20 |
2013-11-13 |
西芬克斯医药有限公司 |
治疗或预防炎性痛的方法
|
EP2007756B1
(en)
|
2006-04-07 |
2015-08-26 |
Vertex Pharmaceuticals Incorporated |
Modulators of atp-binding cassette transporters
|
US20080027044A1
(en)
|
2006-06-13 |
2008-01-31 |
Kim Lewis |
Prodrug antibiotic screens
|
CA2658959A1
(en)
|
2006-06-23 |
2007-12-27 |
Laboratorios Del Dr. Esteve, S.A. |
Combination of a cholinesterase inhibitor and a compound with 5-ht6 receptor affinity
|
CA2563116A1
(en)
|
2006-07-06 |
2008-01-06 |
Gemin X Biotechnologies Inc. |
Methods for treating or preventing anemia or thrombocytopenia using a triheterocyclic compound
|
EP1878724A1
(en)
|
2006-07-15 |
2008-01-16 |
sanofi-aventis |
A regioselective palladium catalyzed synthesis of benzimidazoles and azabenzimidazoles
|
EP1902733A1
(en)
|
2006-09-19 |
2008-03-26 |
Laboratorios Del Dr. Esteve, S.A. |
Combination of a NMDA-receptor ligand and a compound with 5-HT6 receptor affinity
|
ES2381215T3
(es)
*
|
2006-10-19 |
2012-05-24 |
Signal Pharmaceuticals Llc |
Compuestos heteroarilo, sus composiciones y métodos de tratamiento con ellos
|
TW200827340A
(en)
*
|
2006-11-10 |
2008-07-01 |
Astrazeneca Ab |
Chemical compounds
|
US8383662B2
(en)
|
2006-12-05 |
2013-02-26 |
National Chiao Tung University |
Bicyclic heteroaryl compounds
|
AU2007329480A1
(en)
|
2006-12-05 |
2008-06-12 |
National Chio Tung University |
Indazole compounds
|
US20080161254A1
(en)
|
2007-01-03 |
2008-07-03 |
Virobay, Inc. |
Hcv inhibitors
|
CN101663279A
(zh)
|
2007-01-19 |
2010-03-03 |
阿迪生物科学公司 |
Mek抑制剂
|
CN101016294A
(zh)
|
2007-03-13 |
2007-08-15 |
中国人民武装警察部队医学院 |
具有多种生物活性的取代吲哚-3-基草酰胺衍生物
|
JP2010138072A
(ja)
|
2007-03-29 |
2010-06-24 |
Dainippon Sumitomo Pharma Co Ltd |
新規な縮合ピロール誘導体
|
MX2009013753A
(es)
|
2007-06-26 |
2010-01-26 |
Sanofi Aventis |
Una sintesis regioselectiva catalizada por cobre de bencimidazoles y azabencimidazoles.
|
CN101085779A
(zh)
|
2007-07-11 |
2007-12-12 |
中国人民武装警察部队医学院 |
取代吲哚-3-基草酰表鬼臼毒素衍生物及其盐及其用途
|
EP2018861A1
(en)
|
2007-07-26 |
2009-01-28 |
Laboratorios del Dr. Esteve S.A. |
5HT6-Ligands such as sulfonamide derivatives in drug-induced weight-gain
|
ATE495737T1
(de)
|
2007-08-01 |
2011-02-15 |
Esteve Labor Dr |
Kombination von mindestens zwei 5-ht6-liganden
|
US8501713B2
(en)
|
2007-08-03 |
2013-08-06 |
Summit Corporation Plc |
Drug combinations for the treatment of duchenne muscular dystrophy
|
EP2187883A2
(en)
|
2007-08-10 |
2010-05-26 |
Genelabs Technologies, Inc. |
Nitrogen containing bicyclic chemical entities for treating viral infections
|
CA2698075C
(en)
|
2007-08-27 |
2016-04-12 |
Siga Technologies, Inc. |
Antiviral drugs for treatment of arenavirus infection
|
US9101628B2
(en)
|
2007-09-18 |
2015-08-11 |
The Board Of Trustees Of The Leland Stanford Junior University |
Methods and composition of treating a flaviviridae family viral infection
|
JP5715820B2
(ja)
|
2007-09-18 |
2015-05-13 |
スタンフォード ユニバーシティー |
フラビウイルス科ファミリーのウイルスへの感染を治療する方法ならびに、フラビウイルス科ファミリーのウイルスへの感染を治療するための組成物
|
DE102007048447A1
(de)
|
2007-10-10 |
2009-04-16 |
Bayer Healthcare Ag |
Substituierte Dihydropyrazolthione und ihre Verwendung
|
DE102007049157A1
(de)
|
2007-10-13 |
2009-04-16 |
Bayer Healthcare Ag |
Substituierte Dihydrotriazolone und ihre Verwendung
|
WO2009123776A2
(en)
|
2008-01-15 |
2009-10-08 |
Siga Technologies, Inc. |
Antiviral drugs for treatment of arenavirus infection
|
US7947723B2
(en)
|
2008-02-01 |
2011-05-24 |
Spelman College |
Synthesis and anti-proliferative effect of benzimidazole derivatives
|
TW201000107A
(en)
|
2008-04-09 |
2010-01-01 |
Infinity Pharmaceuticals Inc |
Inhibitors of fatty acid amide hydrolase
|
PL2307402T3
(pl)
|
2008-04-29 |
2013-05-31 |
Novartis Ag |
Pochodne imidazo-pirydyny jako inhibitory kinazy podobnej do receptora aktywiny (ALK4 lub ALK5)
|
US20110039895A1
(en)
|
2008-04-30 |
2011-02-17 |
Glaxo Smith Kline LLC., a corporation |
Prolyl hydroxylase inhibitors
|
CA2723279A1
(en)
|
2008-05-28 |
2009-12-23 |
Wyeth Llc |
3-substituted-1h-indole compounds, their use as mtor kinase and pi3 kinase inhibitors, and their syntheses
|
WO2009158118A2
(en)
|
2008-05-30 |
2009-12-30 |
University Of Notre Dame Du Lac |
Anti-bacterial agents from benzo[d]heterocyclic scaffolds for prevention and treatment of multidrug resistant bacteria
|
CN102124009B
(zh)
|
2008-07-08 |
2014-07-23 |
因特利凯公司 |
激酶抑制剂及其使用方法
|
WO2010030727A1
(en)
|
2008-09-10 |
2010-03-18 |
Wyeth Llc |
3-substituted-1h-indole, 3-substituted-1h-pyrrolo[2,3-b]pyridine and 3-substituted-1h-pyrrolo[3,2-b]pyridine compounds, their use as mtor kinase and pi3 kinase inhibitors, and their syntheses
|
WO2010030360A1
(en)
|
2008-09-11 |
2010-03-18 |
Arena Pharmaceuticals, Inc. |
3H-IMIDAZO[4,5-b]PYRIDIN-5-OL DERIVATIVES USEFUL IN THE TREATMENT OF GPR81 RECEPTOR DISORDERS
|
GB0817576D0
(en)
|
2008-09-25 |
2008-11-05 |
Lectus Therapeutics Ltd |
Calcium ion channel modulators & uses thereof
|
CN101723936B
(zh)
|
2008-10-27 |
2014-01-15 |
上海睿星基因技术有限公司 |
激酶抑制剂及其在药学中的用途
|
WO2010051245A1
(en)
|
2008-11-03 |
2010-05-06 |
Merck Sharp & Dohme Corp. |
Benzimidazole and aza-benzimidazole carboxamides
|
WO2010068287A2
(en)
|
2008-12-11 |
2010-06-17 |
Angion Biomedica Corp. |
Small molecule modulators of hepatocyte growth factor (scatter factor) activity
|
TWI519530B
(zh)
|
2009-02-20 |
2016-02-01 |
艾伯維德國有限及兩合公司 |
羰醯胺化合物及其作為鈣蛋白酶(calpain)抑制劑之用途
|
JP2012520884A
(ja)
|
2009-03-18 |
2012-09-10 |
ザ ボード オブ トラスティーズ オブ ザ リランド スタンフォード ジュニア ユニバーシティー |
フラビウイルス科ウイルス感染症を治療する方法および組成物
|
US20190127365A1
(en)
|
2017-11-01 |
2019-05-02 |
Merck Sharp & Dohme Corp. |
Inhibitors of hepatitis c virus replication
|
US9593108B2
(en)
|
2009-04-06 |
2017-03-14 |
Ptc Therapeutics, Inc. |
Compounds and methods for antiviral treatment
|
WO2010118009A1
(en)
|
2009-04-06 |
2010-10-14 |
Ptc Therapeutics, Inc. |
Hcv inhibitor and therapeutic agent combinations
|
EP2416765B1
(en)
|
2009-04-06 |
2016-03-30 |
PTC Therapeutics, Inc. |
Hcv inhibitor and therapeutic agent combinations
|
CA2756568C
(en)
|
2009-04-06 |
2018-02-13 |
University Health Network |
Kinase inhibitors and method of treating cancer with same
|
BRPI1010514A2
(pt)
|
2009-04-06 |
2019-09-24 |
Ptc Therapeutics Inc |
derivados de indol e métodos para tratamento antiviral
|
WO2010117936A1
(en)
|
2009-04-06 |
2010-10-14 |
Schering Corporation |
Combinations of a hcv inhibitor such as bicyclic pyrrole derivatives and a therapeutic agent
|
CA2754702C
(en)
|
2009-04-22 |
2016-06-07 |
Yukinori Take |
Selective ep4 antagonistic substance for treatment of cancer
|
TWI410418B
(zh)
|
2009-04-29 |
2013-10-01 |
Ind Tech Res Inst |
氮雜薁化合物、藥學組合物與抑制一細胞中蛋白質激酶之活性的方法
|
ES2787599T3
(es)
|
2009-05-13 |
2020-10-16 |
Univ Virginia Patent Foundation |
Inhibidores de leucemia inv(16)
|
GB0910003D0
(en)
|
2009-06-11 |
2009-07-22 |
Univ Leuven Kath |
Novel compounds for the treatment of neurodegenerative diseases
|
AP2012006094A0
(en)
|
2009-06-30 |
2012-02-29 |
Siga Technologies Inc |
Treatment and prevention of dengue virus infections.
|
WO2011002520A2
(en)
|
2009-07-02 |
2011-01-06 |
Angion Biomedica Corp. |
Small molecule inhibitors of parp activity
|
EP2464227A4
(en)
|
2009-08-10 |
2013-02-20 |
Galenea Corp |
COMPOUNDS AND METHODS OF USE
|
SG178963A1
(en)
|
2009-09-03 |
2012-04-27 |
Allergan Inc |
Compounds as tyrosine kinase modulators
|
US9340555B2
(en)
|
2009-09-03 |
2016-05-17 |
Allergan, Inc. |
Compounds as tyrosine kinase modulators
|
KR101552760B1
(ko)
|
2009-12-18 |
2015-09-11 |
미쓰비시 타나베 파마 코퍼레이션 |
신규 항혈소판약
|
US8501770B2
(en)
|
2009-12-30 |
2013-08-06 |
Arqule, Inc. |
Substituted imidazopyridinyl-aminopyridine compounds
|
JP6152643B2
(ja)
|
2010-02-22 |
2017-06-28 |
株式会社AskAt |
Il−23媒介疾患を治療するためのep4受容体拮抗薬の使用
|
WO2011116176A1
(en)
|
2010-03-17 |
2011-09-22 |
Sirtris Pharmaceuticals Inc. |
3-substitued imidazo (4, 5-b) pyridines and analogs as sirtuin modulators
|
PE20130211A1
(es)
|
2010-04-02 |
2013-03-22 |
Senomyx Inc |
Modificador del sabor dulce
|
CN103601683B
(zh)
|
2010-04-16 |
2016-03-30 |
中国科学院上海药物研究所 |
苯并杂环类化合物及其制备方法和用途
|
JP5960688B2
(ja)
|
2010-05-17 |
2016-08-02 |
インコゼン セラピューティクス プライベート リミテッド |
プロテインキナーゼ調節物質としての新規3,5−二置換−3h−[1,2,3]トリアゾロ[4,5−b]ピリジン化合物
|
WO2011153310A1
(en)
|
2010-06-02 |
2011-12-08 |
Trius Therapeutics |
Dihydrofolate reductase inhibitors
|
WO2012003576A1
(en)
*
|
2010-07-06 |
2012-01-12 |
Université de Montréal |
Imidazopyridine, imidazopyrimidine and imidazopyrazine derivatives as melanocortin-4 receptor modulators
|
WO2012009258A2
(en)
|
2010-07-13 |
2012-01-19 |
Edward Roberts |
Peptidomimetic galanin receptor modulators
|
WO2012044567A2
(en)
|
2010-09-30 |
2012-04-05 |
Merck Sharp & Dohme Corp. |
Imidazole derivatives
|
US10005750B2
(en)
|
2010-10-06 |
2018-06-26 |
J-Pharma Co., Ltd. |
Developing potent urate transporter inhibitors: compounds designed for their uricosuric action
|
WO2012065065A1
(en)
|
2010-11-12 |
2012-05-18 |
Follica, Inc. |
Methods and compositions for modulating hair growth, wound healing and scar revision
|
GB201021104D0
(en)
|
2010-12-13 |
2011-01-26 |
Univ Leuven Kath |
Novel compounds for the treatment of neurodegenerative diseases
|
GB201021103D0
(en)
|
2010-12-13 |
2011-01-26 |
Univ Leuven Kath |
New compounds for the treatment of neurodegenerative diseases
|
DK2669270T3
(en)
|
2011-01-28 |
2018-02-26 |
Sato Pharma |
Indole-related compounds such as URAT1 inhibitors
|
USRE47009E1
(en)
|
2011-02-01 |
2018-08-28 |
The Children's Hospital Of Philadelphia |
HDAC inhibitors and therapeutic methods using the same
|
WO2012107465A1
(en)
|
2011-02-09 |
2012-08-16 |
F. Hoffmann-La Roche Ag |
Heterocyclic compounds as pi3 kinase inhibitors
|
ES2533042T3
(es)
|
2011-02-25 |
2015-04-07 |
Takeda Pharmaceutical Company Limited |
Oxazinopteridinas y oxazinopteridinonas N-sustituidas
|
CN103501610A
(zh)
|
2011-03-09 |
2014-01-08 |
西建阿维拉米斯研究公司 |
Pi3激酶抑制剂和其用途
|
CN103443080B
(zh)
|
2011-03-16 |
2016-10-12 |
田边三菱制药株式会社 |
具有trpm8拮抗活性的磺酰胺化合物
|
WO2012129562A2
(en)
|
2011-03-24 |
2012-09-27 |
The Scripps Research Institute |
Compounds and methods for inducing chondrogenesis
|
CN103608014A
(zh)
|
2011-03-24 |
2014-02-26 |
罗楹 |
激酶抑制剂在治疗和预防炎症疾病中的用途
|
EP2518071A1
(en)
|
2011-04-29 |
2012-10-31 |
Almirall, S.A. |
Imidazopyridine derivatives as PI3K inhibitors
|
WO2012154888A1
(en)
|
2011-05-09 |
2012-11-15 |
Proteostasis Therapeutics, Inc. |
Compounds for treating protein folding disorders
|
JP5959330B2
(ja)
|
2011-06-17 |
2016-08-02 |
田辺三菱製薬株式会社 |
新規抗血小板薬
|
WO2013052395A1
(en)
|
2011-10-06 |
2013-04-11 |
Merck Sharp & Dohme Corp. |
1,3-substituted azetidine pde10 inhibitors
|
WO2013053045A1
(en)
|
2011-10-12 |
2013-04-18 |
Beta Pharma Canada Inc. |
Heterocyclic molecules as apoptosis inducers
|
WO2013078254A1
(en)
|
2011-11-22 |
2013-05-30 |
Array Biopharma Inc. |
Bicyclic heteroaryl derivatives as kinase inhibitors
|
US8785459B2
(en)
|
2011-12-27 |
2014-07-22 |
Development Center For Biotechnology |
Quinazoline compounds as kinase inhibitors
|
US20150119402A1
(en)
|
2012-05-08 |
2015-04-30 |
The Regents Of The University Of California |
Alpha 7 nicotinic acetylcholine allosteric modulators, their derivatives and uses thereof
|
CN104428293B
(zh)
|
2012-06-11 |
2018-06-08 |
Ucb生物制药私人有限公司 |
调节TNFα的苯并咪唑类
|
AU2013299841B8
(en)
|
2012-08-07 |
2017-01-05 |
Array Biopharma Inc. |
Pharmaceutical combinations comprising a B-Raf inhibitor, an EGFR inhibitor and optionally a PI3K-alpha inhibitor
|
KR20150058284A
(ko)
|
2012-09-21 |
2015-05-28 |
사노피 |
Apj 수용체 조절자로서의 벤조이미다졸-카르복시산 아미드 유도체
|
WO2014047427A2
(en)
|
2012-09-21 |
2014-03-27 |
Vanderbilt University |
Substituted benzofuran, benzothiophene and indole mcl-1 inhibitors
|
GB201217285D0
(en)
|
2012-09-27 |
2012-11-14 |
Univ Central Lancashire |
Indole derivatives
|
AU2013344464A1
(en)
|
2012-11-16 |
2015-05-21 |
The Regents Of The University Of California |
Pictet-Spengler ligation for protein chemical modification
|
MX365950B
(es)
|
2013-03-13 |
2019-06-19 |
Flatley Discovery Lab Llc |
Compuestos de piridazinona y metodos para el tratamiento de la fibrosis quistica.
|
EP2970266B1
(en)
|
2013-03-15 |
2018-01-31 |
Epizyme, Inc. |
1-phenoxy-3-(alkylamino)-propan-2-ol derivatives as carm1 inhibitors and uses thereof
|
MX2015013328A
(es)
|
2013-03-19 |
2016-02-26 |
Askat Inc |
Uso de antagonistas del receptor de ep4 en el tratamiento de enfermedad de cartilago.
|
US9357781B2
(en)
|
2013-05-03 |
2016-06-07 |
Inscent, Inc. |
Honeybee repellents and uses thereof
|
JP2016527184A
(ja)
|
2013-05-24 |
2016-09-08 |
イオメット ファーマ リミテッド |
Slc2a輸送体阻害剤
|
BR112016000059B1
(pt)
*
|
2013-07-02 |
2020-12-29 |
Syngenta Participations Ag |
compostos heterociclos bi ou tricíclicos, composição compreendendo os referidos compostos, método para combater e controlar pragas, método para a proteção de material de propagação vegetal do ataque por pragas e material de propagação vegetal revestido com a referida composição
|
KR20160036053A
(ko)
|
2013-07-31 |
2016-04-01 |
메르크 파텐트 게엠베하 |
Btk 저해제로서 피리딘, 피리미딘, 및 피라진, 및 이들의 용도
|
CA2922341C
(en)
|
2013-08-28 |
2022-06-07 |
Vanderbilt University |
Substituted indole mcl-1 inhibitors
|
CN104447727B
(zh)
|
2013-09-02 |
2018-04-27 |
广东东阳光药业有限公司 |
取代的氨基嘧啶类化合物及其使用方法和用途
|
WO2015073528A1
(en)
|
2013-11-12 |
2015-05-21 |
Proteostasis Therapeutics, Inc. |
Proteasome activity enhancing compounds
|
GB201321739D0
(en)
|
2013-12-09 |
2014-01-22 |
Ucb Pharma Sa |
Therapeutic agents
|
GB201321741D0
(en)
|
2013-12-09 |
2014-01-22 |
Ucb Pharma Sa |
Therapeutic agents
|
WO2015138273A1
(en)
|
2014-03-13 |
2015-09-17 |
Merck Sharp & Dohme Corp. |
2-pyrazine carboxamides as spleen tyrosine kinase inhibitors
|
MX2020010847A
(es)
|
2014-05-13 |
2021-07-16 |
Hoffmann La Roche |
Compuestos heterocíclicos deuterados y su uso como agentes formadores de imágenes.
|
CN105732464A
(zh)
|
2014-12-31 |
2016-07-06 |
杏国新药股份有限公司 |
一种规模化生产吲哚化合物的方法
|
US9809539B2
(en)
|
2015-03-03 |
2017-11-07 |
Shuttle Pharmaceuticals, Llc |
Dual function molecules for histone deacetylase inhibition and ataxia telangiectasia mutated activation and methods of use thereof
|
AR104259A1
(es)
|
2015-04-15 |
2017-07-05 |
Celgene Quanticel Res Inc |
Inhibidores de bromodominio
|
WO2016176460A1
(en)
|
2015-04-29 |
2016-11-03 |
Janssen Pharmaceutica Nv |
Azabenzimidazoles and their use as ampa receptor modulators
|
CA2983314A1
(en)
|
2015-04-30 |
2016-11-03 |
Memorial Sloan-Kettering Cancer Center |
Mitragynine analogs and uses thereof
|
WO2016196890A1
(en)
|
2015-06-04 |
2016-12-08 |
Vtv Therapeutics Llc |
Inhibitors of hexokinase and methods of use thereof
|
BR112018002763A2
(pt)
|
2015-08-11 |
2018-10-09 |
Connexios Life Sciences Pvt Ltd |
método para cicatrização de ferimentos
|
WO2017064068A1
(en)
*
|
2015-10-14 |
2017-04-20 |
Almirall, S.A. |
New trpa1 antagonists
|
JP6826116B2
(ja)
|
2015-11-25 |
2021-02-03 |
ユーシービー バイオファルマ エスアールエル |
プラスメプシンv阻害薬としてのイミノテトラヒドロピリミジノン誘導体
|
GB201521059D0
(en)
|
2015-11-30 |
2016-01-13 |
Isis Innovation |
Inhibitors of metallo-beta-lactamases
|
GB201603104D0
(en)
|
2016-02-23 |
2016-04-06 |
Ucb Biopharma Sprl |
Therapeutic agents
|
KR102643972B1
(ko)
|
2016-03-30 |
2024-03-07 |
솔루스첨단소재 주식회사 |
유기 발광 화합물 및 이를 이용한 유기 전계 발광 소자
|
SG10201911665UA
(en)
|
2016-04-15 |
2020-01-30 |
Cancer Research Tech Ltd |
Heterocyclic compounds as ret kinase inhibitors
|
CN109689639B
(zh)
|
2016-07-07 |
2022-02-18 |
百时美施贵宝公司 |
作为rock抑制剂的螺内酰胺
|
WO2018093579A1
(en)
*
|
2016-11-16 |
2018-05-24 |
Amgen Inc. |
Triazole phenyl compounds as agonists of the apj receptor
|
WO2018097944A1
(en)
|
2016-11-16 |
2018-05-31 |
Amgen Inc. |
Triazole furan compounds as agonists of the apj receptor
|
MA46824A
(fr)
|
2016-11-16 |
2019-09-25 |
Amgen Inc |
Composés de triazole substitués par alkyle en tant qu'agonistes du récepteur apj
|
KR102512190B1
(ko)
|
2016-12-22 |
2023-03-21 |
일루미나 케임브리지 리미티드 |
쿠마린 화합물 및 형광 표지로서의 이의 용도
|
EP3573619A4
(en)
|
2017-01-27 |
2020-10-28 |
SignalRX Pharmaceuticals, Inc. |
THIENOPYRANONES AND FURANOPYRANONES AS KINASE, BROMODOMAIN AND CHECKPOINT INHIBITORS
|
CN110662544A
(zh)
|
2017-03-24 |
2020-01-07 |
纳诺森公司 |
具有有用的药学应用的稠合三唑并嘧啶化合物
|
GB201708451D0
(en)
|
2017-05-26 |
2017-07-12 |
Univ Oxford Innovation Ltd |
Inhibitors of metallo-beta-lactamases
|
KR20200041294A
(ko)
|
2017-06-21 |
2020-04-21 |
샤이 테라퓨틱스 엘엘씨 |
암, 염증성 질환, 신경발달질환 및 섬유증 질환의 치료를 위하여 Ras 수퍼패밀리와 상호작용하는 화합물
|
US10072045B1
(en)
|
2017-06-26 |
2018-09-11 |
Ramapo Pharmaceuticals, Inc. |
Antibacterial lipopeptides and methods for their preparation and use
|
CN109232362B
(zh)
|
2017-07-10 |
2022-12-27 |
广东东阳光药业有限公司 |
芳杂环类衍生物及其在药物上的应用
|
JP7168650B2
(ja)
|
2017-08-02 |
2022-11-09 |
スピノジェニックス, インコーポレイテッド |
ベンゾチアゾールおよび関連化合物
|
WO2019032720A1
(en)
|
2017-08-09 |
2019-02-14 |
Sanford Burnham Prebys Medical Discovery Institute |
APELIN RECEPTOR AGONISTS AND METHODS OF USE
|
AU2018338314A1
(en)
|
2017-09-22 |
2020-04-09 |
Kymera Therapeutics, Inc |
Protein degraders and uses thereof
|
EP3684366A4
(en)
|
2017-09-22 |
2021-09-08 |
Kymera Therapeutics, Inc. |
CRBN LIGANDS AND USES OF THE LATEST
|
RU2020113612A
(ru)
|
2017-10-11 |
2021-11-12 |
Хемоцентрикс, Инк. |
Лечение фокально-сегментарного гломерулосклероза антагонистами ccr2
|
KR20190043437A
(ko)
|
2017-10-18 |
2019-04-26 |
씨제이헬스케어 주식회사 |
단백질 키나제 억제제로서의 헤테로고리 화합물
|
WO2019113523A1
(en)
|
2017-12-08 |
2019-06-13 |
Ashok Bajji |
Compounds and therapeutic uses thereof
|
WO2019136442A1
(en)
|
2018-01-08 |
2019-07-11 |
Kleo Pharmaceuticals, Inc. |
Cd16a binding agents and uses thereof
|
WO2019169193A1
(en)
|
2018-03-01 |
2019-09-06 |
Annapurna Bio Inc. |
Compounds and compositions for treating conditions associated with apj receptor activity
|
US20210130312A1
(en)
|
2018-04-03 |
2021-05-06 |
Children's Hospital Medical Center |
Inhibitors of eya3-protein tyrosine phosphatase in dna damage repair signaling of pulmonary arterial hypertension
|
WO2019199979A1
(en)
|
2018-04-10 |
2019-10-17 |
The General Hospital Corporation |
Antibacterial compounds
|
US11299473B2
(en)
|
2018-04-13 |
2022-04-12 |
Incyte Corporation |
Benzimidazole and indole compounds and uses thereof
|
US10973834B2
(en)
|
2018-04-16 |
2021-04-13 |
Arrys Therapeutics, Inc. |
EP4 inhibitors and use thereof
|
WO2019222272A1
(en)
|
2018-05-14 |
2019-11-21 |
Nuvation Bio Inc. |
Anti-cancer nuclear hormone receptor-targeting compounds
|
BR112020026580A2
(pt)
|
2018-06-27 |
2021-03-23 |
Proteostasis Therapeutics, Inc. (Fem) |
Compostos, composição farmacêutica e métodos para tratar um paciente
|
CN110835333B
(zh)
|
2018-08-16 |
2022-10-18 |
中国药科大学 |
苯并咪唑取代唑类化合物及其用途
|
SG11202102367TA
(en)
|
2018-09-18 |
2021-04-29 |
Terns Inc |
Compounds for treating certain leukemias
|
CN113164454A
(zh)
|
2018-09-28 |
2021-07-23 |
奥克塞拉有限公司 |
Vap-1的抑制剂
|
RS65335B1
(sr)
|
2018-10-05 |
2024-04-30 |
Annapurna Bio Inc |
Jedinjenja i kompozicije za lečenje stanja povezanih sa aktivnošću receptora apj
|
WO2020146532A1
(en)
|
2019-01-08 |
2020-07-16 |
Sparks Steven |
Metalloenzyme inhibitor compounds
|
WO2020160225A1
(en)
|
2019-01-30 |
2020-08-06 |
Ohio State Innovation Foundation |
ESTROGEN RECEPTOR BETA (ERβ) AGONISTS FOR THE TREATMENT OF FIBROTIC CONDITIONS
|
MX2021010701A
(es)
|
2019-03-05 |
2022-02-21 |
F Star Therapeutics Inc |
Compuestos, composiciones y metodos para el tratamiento de enfermedad.
|
EP3946618A1
(en)
|
2019-04-05 |
2022-02-09 |
Storm Therapeutics Ltd |
Mettl3 inhibitory compounds
|
WO2020243457A1
(en)
|
2019-05-29 |
2020-12-03 |
Viogen Biosciences, Llc |
Compounds and therapeutic uses thereof
|
US11136318B2
(en)
|
2019-06-21 |
2021-10-05 |
Noramco, Llc |
Processes for the preparation of aryl hydrocarbon receptor ligands
|
US11702404B2
(en)
|
2019-10-25 |
2023-07-18 |
Gilead Sciences, Inc. |
GLP-1R modulating compounds
|
WO2021096314A1
(ko)
|
2019-11-15 |
2021-05-20 |
가천대학교 산학협력단 |
신규한 벤즈이미다졸 유도체 및 이의 용도
|
US20210300912A1
(en)
|
2019-12-20 |
2021-09-30 |
Ikena Oncology, Inc. |
Aryl hydrocarbon receptor (ahr) agonists and uses thereof
|
KR20220133271A
(ko)
|
2020-01-29 |
2022-10-04 |
길리애드 사이언시즈, 인코포레이티드 |
Glp-1r 조절 화합물
|
WO2021178362A1
(en)
|
2020-03-03 |
2021-09-10 |
VenatoRx Pharmaceuticals, Inc. |
Hepatitis b capsid assembly modulators
|
US20230114408A1
(en)
|
2020-03-11 |
2023-04-13 |
Ohio State Innovation Foundation |
Methods of modulating t-cell activation using estrogen receptor beta (erb) agonists
|